Publication: Characterization of COPD Admissions During the First COVID-19 Outbreak.
Loading...
Identifiers
Date
2021-06-03
Authors
Cosio, Borja G
Shafiek, Hanaa
Toledo-Pons, Nuria
Iglesias, Amanda
Barcelo, Margalida
Represas-Represas, Cristina
Comeche, Lorena
Catalan, Pablo
Fernandez-Villar, Alberto
Lopez-Campos, Jose Luis
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Exacerbations of COPD (ECOPD) are a frequent cause of hospitalization that seemed to ameliorate during the COVID outbreak. We aimed to evaluate the clinical characteristics of COPD-related hospital admissions and mortality in relation to the presence of COVID-19. We conducted a case-control study of patients admitted in four teaching hospitals throughout Spain between March 15 and April 30, 2020. Hospital admissions of respiratory cause with and without PCR-proven SARS-CoV-2 infection in patients with COPD were evaluated. Baseline and episode-related clinical characteristics were analyzed. Logistic regression analysis was performed to evaluate the risk for mortality. During the study period, 2101 patients were admitted for respiratory worsening, 1200 (57.1%) with COVID-19. A total of 228 (10.8%) were admitted due to COPD worsening, of whom 52 (22.8%) tested positive for COVID-19. COPD patients with COVID-19, when compared to those without COVID-19, were more frequently males with better lung function (FEV1 postbronchodilator 71% vs 46% respectively, p Hospitalizations for ECOPD without COVID-19 were more frequent than COPD with COVID-19 during the first outbreak, but the latter were associated with higher mortality and low eosinophil counts that warrant further analysis.
Description
MeSH Terms
COVID-19
Case-Control Studies
Disease Outbreaks
Hospitalization
Humans
Male
Pulmonary Disease, Chronic Obstructive
SARS-CoV-2
Spain
Case-Control Studies
Disease Outbreaks
Hospitalization
Humans
Male
Pulmonary Disease, Chronic Obstructive
SARS-CoV-2
Spain
DeCS Terms
CIE Terms
Keywords
COPD exacerbation, hospitalization, inhaled corticosteroids, mortality